Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Non-Current Assets of $6.8 billion for Q1 2026, up 368.06% year-over-year from $1.5 billion in Q1 2025, and down 10.72% quarter-over-quarter from $7.7 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Non-Current Assets for 18 consecutive years, with $6.8 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 368.06% year-over-year to $6.8 billion; the TTM figure through Mar 2026 stood at $18.6 billion (up 1015.69% YoY), while the FY2025 annual figure was $7.7 billion, up 21.1% from the prior year.
- Non-Current Assets declined to $6.8 billion in Q1 2026 per BIO's latest filing, from $7.7 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.1 billion in Q1 2022 and bottomed at -$3.2 billion in Q4 2022.
- Historically, Non-Current Assets has averaged $3.9 billion across 5 years, with a median of $6.8 billion in 2026.
- Annual changes were most pronounced in 2024 — Non-Current Assets plunged 134.58% — and 2026, when it jumped 368.06%.
- Bio-Rad Laboratories' Non-Current Assets stood at -$3.2 billion in 2022, then rose by 19.07% to -$2.6 billion in 2023, then jumped by 347.88% to $6.3 billion in 2024, then climbed by 21.1% to $7.7 billion in 2025, then slipped by 10.72% to $6.8 billion in 2026.
- Business Quant data shows BIO's Non-Current Assets at $6.8 billion in Q1 2026, $7.7 billion in Q4 2025, and $6.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 7.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Bn |
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.67 Bn |
| Sep 30, 2025 | 6.85 Bn |
| Jun 30, 2025 | -2.80 Bn |
| Mar 31, 2025 | -2.55 Bn |
| Dec 31, 2024 | 6.33 Bn |
| Sep 30, 2024 | -2.75 Bn |
| Jun 30, 2024 | -3.06 Bn |
| Mar 31, 2024 | -2.57 Bn |
| Dec 31, 2023 | -2.56 Bn |
| Sep 30, 2023 | 8.75 Bn |
| Jun 30, 2023 | 8.84 Bn |
| Mar 31, 2023 | 10.39 Bn |
| Dec 31, 2022 | -3.16 Bn |
| Sep 30, 2022 | 8.92 Bn |
| Jun 30, 2022 | 9.43 Bn |
| Mar 31, 2022 | 11.07 Bn |
| Dec 31, 2021 | -1.78 Bn |
| Sep 30, 2021 | 17.49 Bn |